TGA Approval

WINGLORE ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial (174327)

ARTG ID

174327

ARTG Name

WINGLORE ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

July 4, 2011

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

Ingredient Name

Ipilimumab

Empowering clinical research with data-driven insights and AI-powered tools.

WINGLORE ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial (174327) - TGA 批准文号 | MedPath